Key Drivers
- Cash Flow
- Liquidity Strength
- Loss Pressure
AIAI Summary
NEOG should be viewed as a two-speed story—Food Safety is emerging as the durable growth and margin engine, while Animal Safety's supplier/disruption issues remain the main blocker to a full rerating, so the key watchpoint is whether rising free cash flow and the genomics divestiture can fund stabilization fast enough to offset execution risk.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Flow
- •Liquidity Strength
- •Loss Pressure
NEOG shows a mixed but improving picture: liquidity and cash generation strengthened materially, yet persistent operating/net losses and a high intangible-heavy asset base keep the outlook cautious.
Price Behavior
Key Price Behavior Insights:
- •Support Holding
- •Resistance Test
- •Quick Rebound
NEOG has shown a modestly positive trend over the last month, holding support around $8.99-$8.83 but still needing a clean breakout above $9.58 to confirm stronger upside.
Late-June dip from around $9.50 to $8.99 quickly rebounded, showing buyers stepped in
Sentiment & News
Key News Insights:
- •Product expansion
- •Guidance lift
- •Debt pressure
Neogen's expanding food and animal safety business is boosting growth, stock performance, and guidance, but debt, competition, and cost pressures remain key headwinds.
The news is modestly positive for NEOG as execution and growth catalysts support upside, but valuation and financial risks may limit near-term enthusiasm
Similar Companies in Healthcare
Other companies in the same sector with AI ratings